DR. JAMES MICHAEL PLUDA, M.D.
Osteopathic Medicine at Harvest Moon Ln, Hatfield, PA
License number
Pennsylvania MD428224
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
1613 Harvest Moon Ln, Hatfield, PA 19440
Phone
(215) 361-3456
Personal information
See more information about JAMES MICHAEL PLUDA at radaris.comName
Address
Phone
1613 Harvest Moon Ln, Hatfield, PA 19440
Lansdale, PA
1613 Harvest Moon Ln, Hatfield, PA 19440
Professional information
Dr. James M Pluda, Hatfield PA - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
1613 Harvest Moon Ln, Hatfield 19440
(215) 361-3456 (Phone)
(215) 361-3456 (Phone)
Certifications:
Internal Medicine, 1983, Medical Oncology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 1980
Mayo Clinic-Rochester
Natl Canc Inst
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 1980
Mayo Clinic-Rochester
Natl Canc Inst
Method Of Treating Cancers With Saha And Pemetrexed
US Patent:
2007011, May 24, 2007
Filed:
Nov 3, 2006
Appl. No.:
11/592512
Inventors:
James Pluda - Hatfield PA, US
Stanley Frankel - Yardley PA, US
Victoria Richon - Wellesley MA, US
Steven Averbuch - North Wales PA, US
Judy Chiao - Berkeley Heights NJ, US
Stanley Frankel - Yardley PA, US
Victoria Richon - Wellesley MA, US
Steven Averbuch - North Wales PA, US
Judy Chiao - Berkeley Heights NJ, US
International Classification:
A61K 31/519, A61K 31/19
US Classification:
514265100, 514575000
Abstract:
The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of an anti-cancer agent. The HDAC inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC inhibitor and the anti-cancer agent may be additive or synergistic.
Method Of Treating Cancers With Saha And Pemetrexed
US Patent:
2008026, Oct 30, 2008
Filed:
May 20, 2008
Appl. No.:
12/154089
Inventors:
James Pluda - Hatfield PA, US
Stanley R. Frankel - Yardley PA, US
Victoria M. Richon - Wellesley MA, US
Steven Averbuch - North Wales PA, US
Judy H. Chiao - Berkeley Heights NJ, US
Stanley R. Frankel - Yardley PA, US
Victoria M. Richon - Wellesley MA, US
Steven Averbuch - North Wales PA, US
Judy H. Chiao - Berkeley Heights NJ, US
International Classification:
A61K 31/56, A61K 31/519
US Classification:
514180, 5142651
Abstract:
The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of an anti-cancer agent. The HDAC inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC inhibitor and the anti-cancer agent may be additive or synergistic.